Research Catalog

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.

Title
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Publication
[Washington, D.C.] : U.S. Government Printing Office, [2013]

Details

Description
3 microfiches (iv, 194 pages) : negative, illustrations; 11 x 15 cm
Subject
  • United States. Food and Drug Administration > Rules and practice
  • Drug approval > United States
  • Generic drugs > Government policy > United States
  • Biologicals > Government policy > United States
  • Drug accessibility > United States
  • Fees, Administrative > United States
Note
  • Shipping list no.: 2013-0371-M.
  • Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
  • "Serial no. 112-114."
Bibliography (note)
  • Includes bibliographical references.
Call Number
GPO Microfiche Y 4.C 73/8:112-114
OCLC
marcive861617562
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Title
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
Publisher
[Washington, D.C.] : U.S. Government Printing Office, [2013]
Type of Content
text
Type of Medium
microform
Type of Carrier
microfiche
Bibliography
Includes bibliographical references.
Other Form:
Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages (OCoLC)855764761
Online version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages (OCoLC)855764785
Gpo Item No.
1019-B-01 (MF)
Sudoc No.
Y 4.C 73/8:112-114
View in Legacy Catalog